In Situ Hybridization (ISH) Market Overview, Growth, and Oppotunities by 2031
Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031Coverage: In Situ Hybridization (ISH) Market covers analysis By Technology ( Chromogenic In Situ Hybridization, Fluorescence In Situ Hybridization ); Application ( Immunology, Microbiology, Cancer Diagnostic, Neuroscience and Infectious Diseases ); End-User ( Biotechnology/Pharmaceutical Companies, Academic and Research Institutes and Molecular Diagnostic Labs ) , and Geography (North America, Europe, Asia Pacific, and South and Central America)
- Report Date : Aug 2025
- Report Code : TIPHE100001167
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 150
MARKET OVERVIEW
In Situ Hybridization (ISH) is a process that utilizes labeled DNA or RNA probes to detect complementary DNA or RNA sites in a piece of tissue or in cytological preparation. This technique allows to gain temporary and three-dimensional information about gene expression and genetic site. The in-situ hybridization is similar to the blot hybridization.
MARKET SCOPE
The "Global In Situ Hybridization (ISH) Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the In Situ Hybridization (ISH) market with detailed market segmentation by technology, application, end user, and geography. The report provides key statistics on the market status of the leading In Situ Hybridization (ISH) market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on technology, the global In Situ Hybridization (ISH) market is segmented into Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization.
- On the basis of application, the market is segmented into Immunology, Microbiology, Cancer Diagnostic, Neuroscience and Infectious Diseases.
- On the basis of End-User, the market is segmented into Biotechnology/Pharmaceutical Companies, Academic & Research Institutes and Molecular Diagnostic Labs.
MARKET DYNAMICS
Drivers
- Increasing Incidence Of Genetic Disorder And Cancer
- Rising Investment In The Field Of Biotechnological And Pharmaceutical R&D Activities
Restraints
- Lack of skilled professionals
- Stringent Regulatory Framework
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The In Situ Hybridization (ISH) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the In Situ Hybridization (ISH) market in these regions.
IMPACT OF COVID-19 ON IN SITU HYBRIDIZATION (ISH) MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. However, in situ hybridization (ISH) and immunohistochemistry (IHC) are essential tools to characterize SARS-CoV-2 infection and tropism in naturally and experimentally infected animals and also for diagnostic purposes. Here, we describe three RNAscope®-based ISH assays targeting the ORF1ab, spike, and nucleocapsid genes and IHC assays targeting the spike and nucleocapsid proteins of SARS-CoV-2.The ongoing COVID-19 pandemic has surged the central position of In Situ Hybridization (ISH) in outbreak control.
MARKET PLAYERS
The report covers key developments in the In Situ Hybridization (ISH) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from In Situ Hybridization (ISH) market are anticipated to lucrative growth opportunities in the future with the rising demand for In Situ Hybridization (ISH) in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the In Situ Hybridization (ISH) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott.
- Thermofisher Scientific, Inc.
- PerkinElmer Inc.
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Danaher
- BioGenex
- Bio SB
- Exiqon (QIAGEN)
- Oxford Gene Technology
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
In Situ Hybridization (ISH) Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ XX million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2025 - 2031) | XX% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
The List of Companies
1. Abbott.
2. Thermofisher Scientific, Inc.
3. PerkinElmer Inc.
4. Merck KGaA
5. F. Hoffmann-La Roche Ltd
6. Danaher
7. BioGenex
8. Bio SB
9. Exiqon (QIAGEN)
10. Oxford Gene Technology
11. Biocare Medical
12. Abnova Corporation
13. Bio-Techne
14. Creative Bioarray
Get Free Sample For